Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Charles River Lbrtrs ntrntl In - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CRL
New York
8731
https://www.criver.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Charles River Lbrtrs ntrntl In
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
- Apr 22nd, 2024 1:40 pm
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
- Apr 22nd, 2024 12:00 pm
Here's Why You Should Retain Charles River (CRL) Stock Now
- Apr 16th, 2024 3:50 pm
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
- Apr 16th, 2024 12:00 pm
ICLR or CRL: Which Is the Better Value Stock Right Now?
- Apr 12th, 2024 3:40 pm
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
- Apr 12th, 2024 12:00 pm
Charles River (CRL) Forges Collaboration With Ship of Theseus
- Apr 11th, 2024 1:10 pm
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
- Apr 11th, 2024 12:00 pm
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
- Apr 9th, 2024 12:00 pm
Charles River to Perform Plasmid Production for Ship of Theseus
- Apr 4th, 2024 12:00 pm
Charles River Laboratories International, Inc.'s (NYSE:CRL) Stock Is Going Strong: Is the Market Following Fundamentals?
- Apr 1st, 2024 2:57 pm
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
- Apr 1st, 2024 12:00 pm
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
- Mar 27th, 2024 12:00 pm
Charles River (CRL) Extends Gene Therapy Deal With NUS Medicine
- Mar 26th, 2024 1:39 pm
U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies
- Mar 23rd, 2024 1:00 pm
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
- Mar 21st, 2024 12:00 pm
Why Is Charles River (CRL) Up 6.2% Since Last Earnings Report?
- Mar 15th, 2024 3:30 pm
Charles River (CRL) Extends Gene Therapy Offering With New Pact
- Mar 15th, 2024 2:30 pm
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
- Mar 14th, 2024 12:00 pm
Charles River Laboratories to Present at Barclays Global Healthcare Conference
- Mar 12th, 2024 12:00 pm
Scroll